causal
US taxpayer funds global drug innovation via unconstrained pricing
An enormous portion of pharmaceutical profitability comes from unconstrained pricing that Medicare pays out of American taxpayers' pockets; other countries (Israel, France, England, Romania) pay far less, so the drug would not exist without the large profit opportunity in America, meaning US taxpayers effectively subsidize cheaper drugs worldwide.
causalpending
Speaker
Russ RobertsEvidence Quote
“that drug wouldn't exist without that enormous opportunity in America to make a lot of money.”
Created: 6/13/2026, 3:32:57 AM
Your notes
Loading notes...